A $46.4 million DARPA study to develop and test shelf stable artificial blood is being led by UMSOM professor and KaloCyte co-founder Allan Doctor.Read more.
LifeGel™ is the first and only hemostatic agent to receive Breakthrough Device Designation seeking a new and highly differentiated indication: in surgical procedures.Read more.
Eight teams received funding and support to advance their medical device technologies.Read more.
With $1.1 billion in combined research expenditures, the Baltimore/College Park enterprise placed 16th overall nationally and 10th among all public institutions in Research & Development (R&D) spending.Read more
The UMB startup is working from the New Ventures lab in the BioPark.Read more
UM Ventures has launched a series of initiatives for the Center for Maryland Advanced Ventures, including:
NEW ACCELERATOR: Trajectory Next
Trajectory Next is a 12-week post-accelerator program for digital health, bio-health, and life sciences startups.
The Baltimore Fund
The Baltimore Fund provides financial incentives to companies affiliated with Maryland Public Higher Education Institutions to locate in a network of innovation centers in Baltimore City.
The UMCP Fischell Institute
The UMCP Fischell Institute for Biomedical Devices is opening a satellite location at UMB to accelerate the development of innovative medical devices.
Maryland Momentum Fund
The University System of Maryland created the Maryland Momentum Fund, a $25 million early-stage investment program investing in USM-affiliated companies. The Maryland Momentum Fund is staffed by UM Ventures.
University of Maryland, Baltimore Institute for Clinical and Translational Research
The University of Maryland, Baltimore Institute for Clinical and Translational Research (ICTR) is pleased to announce the first round of UMB ICTR Accelerated Translational Incubator Pilot (ATIP) Grant funding opportunities for 2018-2019.
UM Ventures is a joint initiative of the University of Maryland, Baltimore and University of Maryland, College Park to commercialize technologies and expand industry collaboration.